Health and Human Rights Summit – Advancing the Wellbeing of People Who Use Drugs

A three-day event bringing together AIVL Member Organisations, Affiliate Members, partners, and allies to engage in presentations, workshops, and panel discussions focused on the health and human rights of people who use drugs.

DATE 09 Dec 2024to 11 Dec 2024
TIME 8:30 am - 4:00 pm
DELIVERY In-Person
LOCATION Crowne Plaza, Adelaide
SPEAKERSJoão Santa Maria / GAT (Group of Activists in Treatment)Malu Salazar / GAT (Group of Activists in Treatment)Dr Annie Madden AOMore
TICKETED Yes
CATERED Yes
ACCESSIBILITY Yes

Join us for a three-day event bringing together AIVL Member Organisations, Affiliate Members, partners, and allies to engage in presentations, workshops, and panel discussions focused on the health and human rights of people who use drugs.

Days 1 & 2: Invite-only sessions.
Day 3: Open to the public! Tickets are available now.

 

 

João Santa Maria

GAT (Group of Activists in Treatment)

Peer Worker and Co-coordinator

João Santa Maria is a peer worker and co-coordinator at GAT in Mouraria, with a journey marked by a commitment to defending human rights. A drug user and person who experienced homelessness for 13 years, João l...

View Bio
Frame Created with Sketch.

João Santa Maria

GAT (Group of Activists in Treatment)

Peer Worker and Co-coordinator

João Santa Maria is a peer worker and co-coordinator at GAT in Mouraria, with a journey marked by a commitment to defending human rights. A drug user and person who experienced homelessness for 13 years, João lives with HIV and is an advocate for the rights of people who use drugs and those living with HIV. He joined GAT (Group of Activists in Treatment) in 2005, and since 2012, has worked as a peer supporter at the GAT IN Mouraria project, a harm reduction centre and peer-led drug consumption room.

Malu Salazar is a harm reduction worker and co-coordinator at GAT (Group of Activists in Treatment) in Mouraria

Malu Salazar

GAT (Group of Activists in Treatment)

Harm Reduction Worker and Co-coordinator

Malu Salazar is a harm reduction worker and co-coordinator at GAT (Group of Activists in Treatment) in Mouraria. She is a social worker and activist for the rights of people who use drugs. She has been working in...

View Bio
Frame Created with Sketch.
Malu Salazar is a harm reduction worker and co-coordinator at GAT (Group of Activists in Treatment) in Mouraria

Malu Salazar

GAT (Group of Activists in Treatment)

Harm Reduction Worker and Co-coordinator

Malu Salazar is a harm reduction worker and co-coordinator at GAT (Group of Activists in Treatment) in Mouraria. She is a social worker and activist for the rights of people who use drugs. She has been working in the harm reduction movement since 2018 with the communities of people who use drugs, migrants and sex workers. Malu is a member of EURONPUD (European Network of People Who Use Drugs) and a peer volunteer in Kosmicare. Currently, Malu is also working at de Regenboog Groep (Amsterdam, Netherlands) as a harm reduction worker in a drug consumption room and walk-in centre for migrants who use drugs and experience homelessness.

Dr Annie Madden AO

Dr Annie Madden AO

Project Lead at the International Network of People Who Use Drugs (INPUD) and Executive Officer of Harm Reduction Australia.

Annie is the Executive Director of Harm Reduction Australia and Project Lead at the International Network of People who Use Drugs (INPUD). She is also a principal of 2SqPegs Consulting – a health & social p...

View Bio
Frame Created with Sketch.
Dr Annie Madden AO

Dr Annie Madden AO

Project Lead at the International Network of People Who Use Drugs (INPUD) and Executive Officer of Harm Reduction Australia.

Annie is the Executive Director of Harm Reduction Australia and Project Lead at the International Network of People who Use Drugs (INPUD). She is also a principal of 2SqPegs Consulting – a health & social policy consulting business.

Prior to these appointments, Annie was CEO of the Australian Injecting & Illicit Drug Users League (AIVL) for 16 years until April 2016 and EO of the NSW Users & AIDS Association (NUAA) from 1994 to 2000. She is a founding member of Harm Reduction Australia, is well-published in relation to people who inject drugs, OST and BBVs and has held numerous high-level appointments.

Annie has dedicated her entire professional career to promoting the health and human rights of people who inject drugs.

Robert Simms MLC

Parliament of South Australia

Member of the Legislative Council - The Greens South Australia

Robert Simms is a Member of the Legislative Council in the Parliament of South Australia. Over the past decade Robert has been a passionate advocate for progressive values and South Australian communities at ever...

View Bio
Frame Created with Sketch.

Robert Simms MLC

Parliament of South Australia

Member of the Legislative Council - The Greens South Australia

Robert Simms is a Member of the Legislative Council in the Parliament of South Australia.

Over the past decade Robert has been a passionate advocate for progressive values and South Australian communities at every level of government.

As the first out gay man to represent South Australia in federal parliament, Robert was a strong voice for LGBTI rights in Canberra, from defending Safe Schools programs to holding the Turnbull Government to account over its needlessly divisive and Marriage Equality plebiscite.

He also led the push to overturn an outdated ban on gay men donating blood in Australia, and won Senate support for vital HIV prevention drug PrEP to be fast-tracked in Australia. Locally, Robert also drove the push for the world’s longest Rainbow Walk to be installed in Adelaide’s CBD, laying down a prominent and permanent show of Pride in the heart of the city.

Tom Rees

Manager of the STI and BBV Section at the South Australian Department for Health and Wellbeing and Chair of BBVSS – a subcommittee of the Australian Health Protection Committee.

Tom Rees is the Manager of the STI and BBV Section at the South Australian Department for Health and Wellbeing and Chair of BBVSS – a subcommittee of the Australian Health Protection Committee.    In these ca...

View Bio
Frame Created with Sketch.

Tom Rees

Manager of the STI and BBV Section at the South Australian Department for Health and Wellbeing and Chair of BBVSS – a subcommittee of the Australian Health Protection Committee.

Tom Rees is the Manager of the STI and BBV Section at the South Australian Department for Health and Wellbeing and Chair of BBVSS – a subcommittee of the Australian Health Protection Committee. 

 

In these capacities, Tom provides system leadership and coordination for the public health response to HIV, viral hepatitis and STIs through policy and program development.

 

Tom is committed to working in partnership with government and non-government agencies, researchers, clinicians and affected communities across Australia to deliver on our important national policy objectives in this area, including the World Health Organization’s 2030 HIV and viral hepatitis elimination targets.

Charles Henderson

Burnet Institute

Community Engagement Coordinator

Charles is currently with the Burnet Institute in Melbourne employed as a community engagement coordinator working in community-led hepatitis C implementation and research. He is undertaking qualitative postgrad...

View Bio
Frame Created with Sketch.

Charles Henderson

Burnet Institute

Community Engagement Coordinator

Charles is currently with the Burnet Institute in Melbourne employed as a community engagement coordinator working in community-led hepatitis C implementation and research. He is undertaking qualitative postgraduate research on user experiences on long-acting injectable buprenorphine. He is a global consultant in the health and social drug use arena with 2SqPegs Consulting. He has performed several harm reduction roles in New Zealand including 15 years as Needle Exchange Programme National lead. Since coming to Australia, he has enjoyed roles at Harm Reduction Victoria (HRVic) in Melbourne and New South Wales Users and AIDS Association (NUAA) in Sydney. Charles is committed to improving the health and well-being of drug users and advocating for the lives and human rights of people who use/ inject illicit drugs.

Tim Piatkowski

Dr. Timothy Piatkowski

Griffith University

Peer Researcher

Dr. Timothy Piatkowski is a peer researcher at Griffith University within the School of Applied Psychology and the Centre for Mental Health and Director of the Board for Queensland Injectors Voice for Advocacy an...

View Bio
Frame Created with Sketch.
Tim Piatkowski

Dr. Timothy Piatkowski

Griffith University

Peer Researcher

Dr. Timothy Piatkowski is a peer researcher at Griffith University within the School of Applied Psychology and the Centre for Mental Health and Director of the Board for Queensland Injectors Voice for Advocacy and Action (QuIVAA). His research philosophy is deeply rooted in the principles of harm reduction, emphasising the importance of promoting safer use and informed decision-making regarding illicit substance consumption. Tim’s research focuses on reducing harm and enhancing health among people who use image and performance enhancing drugs (IPEDs). He examines how systemic factors and individual differences influence IPED use and impact the risk of harm, which are subsequently used to inform effective approaches and educational programs that mitigate IPED-related harms while enhancing community engagement with services.

Loren Brener

Loren Brener

Centre for Social Research in Health

Professor

Loren Brener is a Professor at the Centre for Social Research in Health. Her research focuses on stigma and discrimination experienced by people living with blood-borne viruses such as HIV and viral hepatitis and...

View Bio
Frame Created with Sketch.
Loren Brener

Loren Brener

Centre for Social Research in Health

Professor

Loren Brener is a Professor at the Centre for Social Research in Health. Her research focuses on stigma and discrimination experienced by people living with blood-borne viruses such as HIV and viral hepatitis and the impact of this on health outcomes and quality of care.

Elena Cama

Elena Cama

Centre for Social Research in Health

Research Fellow

Elena Cama is a Research Fellow at the Centre for Social Research in Health. Her research focuses on experiences, impacts, and responses to different forms of marginalisation and violence, particularly towards pe...

View Bio
Frame Created with Sketch.
Elena Cama

Elena Cama

Centre for Social Research in Health

Research Fellow

Elena Cama is a Research Fellow at the Centre for Social Research in Health. Her research focuses on experiences, impacts, and responses to different forms of marginalisation and violence, particularly towards people affected by blood-borne viruses and sexually transmissible infections.

Ele Morrison

Australian Injecting and Illicit Drug User League (AIVL)

Deputy Chief Executive Officer

Ele Morrison is the Deputy Chief Executive Officer at AIVL. Ele has worked in harm reduction roles, programs and services since 2001. Her first role was in community development at Melbourne’s first primary hea...

View Bio
Frame Created with Sketch.

Ele Morrison

Australian Injecting and Illicit Drug User League (AIVL)

Deputy Chief Executive Officer

Ele Morrison is the Deputy Chief Executive Officer at AIVL. Ele has worked in harm reduction roles, programs and services since 2001. Her first role was in community development at Melbourne’s first primary health service for people who inject drugs. She went on to support harm reduction and the development of drug user organisations across Asia and Australia.

Jess Doumany

Australian Injecting and Illicit Drug User League (AIVL)

Research Lead

Jess is the Research Lead for AIVL, advocating for people who use and inject drugs through her lived experience. She spearheads the first national Research Strategy developed by and for this community.

AIVL CEO

John G

Australian Injecting and Illicit Drug User League (AIVL)

Chief Executive Officer

John is the CEO of AIVL, leading the strategic vision and development of the organisation anchored in its community and network. With over 20 years of experience in health promotion and harm reduction leadership ...

View Bio
Frame Created with Sketch.
AIVL CEO

John G

Australian Injecting and Illicit Drug User League (AIVL)

Chief Executive Officer

John is the CEO of AIVL, leading the strategic vision and development of the organisation anchored in its community and network. With over 20 years of experience in health promotion and harm reduction leadership nationally and internationally within the community health and social services sectors, John specialises in non-profit management, innovation and peer workforce development.

Accalia Dalmore

SWOP NT & NTAHC

Peer Health Promotions, Communications, Program Coordinator

Accalia Dalmore has worked in advocacy, community engagement, law reform and harm reduction spaces for over 12 years as a peer in Garramilla Darwin and Tarntanya Adelaide. Her engagemnt of community driven respon...

View Bio
Frame Created with Sketch.

Accalia Dalmore

SWOP NT & NTAHC

Peer Health Promotions, Communications, Program Coordinator

Accalia Dalmore has worked in advocacy, community engagement, law reform and harm reduction spaces for over 12 years as a peer in Garramilla Darwin and Tarntanya Adelaide. Her engagemnt of community driven responses  intersects with people who use drugs and sex workers. Presenting at forums, workshops and conferences to advance the rights of both sectors of peers as leaders in policy and reforms. Her current positions are at NTAHC as Peer Health Promotion – Communications and at SWOP NT as SWWUD Coordinator.

Program

Monday Dec 9 (Invite-only Sessions)

Registration Opens 8.30am
Welcome by AIVL9.00am
Acknowledgement of Country9.15am
Acknowledgement of Community 9.30am
KEYNOTE

A ‘One-Stop Shop’ for People Who Use Drugs: The Power of a Peer-Led Harm Reduction Service in Lisbon, Portugal

João Santa Maria is a Peer Worker and Co-coordinator at GAT (Group of Activists in Treatment). Malu Salazar is a Harm Reduction Worker and Co-coordinator at GAT.
9:45am
Morning Tea10:45am
PANEL DISCUSSION

Let’s Talk: Innovation in Peer-led Harm Reduction Programs
11:00am
Lunch12:00pm
Setting the Scene: What Are Our Asks for the Next 5 Years – The AIVL Health and Human Rights Summit Declaration 20241:00pm
A Research Strategy By and For People Who Use Drugs: An Update2:00pm
Afternoon Tea3:00pm
The AIVL Annual General Meeting (AGM) 20243:30pm
End of Day 15:00pm

Tuesday Dec 10 (Invite-only Sessions)

Registration Opens 8.30am
Welcome by AIVL9.00am
Acknowledgement of Country9.15am
Acknowledgement of Community 9.30am
Advancing the Health and Human Rights of People Who Use Drugs Through a Peer-Led Response to Blood-Borne Viruses and Emerging Drugs9:45am
Morning Tea10:45am
Creating a Centre of Research Excellence to Advance the Health and Human Rights of People Who Use Drugs11:00am
Lunch12:00pm
Workshop: What Are Our Asks for the Next 5 Years – The AIVL Health and Human Rights Summit Declaration 20241:00pm
Workshop: Drug Law Reform2:00pm
Afternoon Tea2:45pm
New Theories and Approaches to Reduce Stigma for People Who Use Drugs and Other Priority Populations3:15pm
Evidence to Practice: Strengthening and Elevating Our Harm Reduction Peer Workforce4:00pm
Break5:00pm
AIVL Network Award Ceremony & International Human Rights Day Celebration at Luna 10 Cocktail Bar and Lounge (Level 10 of Crowne Plaza Hotel) 5:50pm – 8:30pm

Wednesday 11 Dec (Public Sessions)

Registration Opens 8.30am
Welcome by AIVL9.00am
Welcome to Country 9.15am
Acknowledgement of Community 9.30am
KEYNOTE

Learning from Portugal in a Decriminalised Context

Malu Salazar is a Harm Reduction Worker and Co-coordinator at GAT (Group of Activists in Treatment). GAT is a community-based harm reduction centre, a ‘one-stop-shop’ for people who use drugs in Lisbon, Portugal.
9:45am
Morning Tea10:45am
KEYNOTE

Insights from the International Network of People Who Use Drugs (INPUD) on How Australia Can Improve the Health and Human Rights of People Who Use Drugs

Dr Annie Madden AO is the Project Lead at the International Network of People Who Use Drugs (INPUD) and Executive Officer of Harm Reduction Australia.
11:00am
Lunch12:00pm
Welcome Back12:45pm
Presentation of the AIVL Health and Human Rights Summit Declaration 1:00pm
Ongoing Commitment from Local and Federal Governments to Work with the Community of People who Use Drugs2:00pm
The Importance of Decriminalisation of People Who Use Drugs to Ensure Equity, Social Justice and Access to Services2:30pm
The Role of Allies in Advancing Health and Human Rights of People Who Use Drugs: Why Peer Leadership is Essential for Lasting Change3:00pm
Afternoon Tea3:45pm
Close4:00pm

Summit Sponsors

FAQ’S

Who should attend the Health and Human Rights Summit public sessions on day three (11 Dec) plus Created with Sketch.

Achieving equity and freedom takes the voices of many – Your presence matters.

Who should attend: 

  • People who use drugs 
  • People who work as or identify as a Peer within the drug-using community 

People working in:  

  • Harm Reduction
  • Alcohol and Other Drugs 
  • Community Services 
  • Corrective Services 
  • Healthcare 
  • Health Promotion and Communication
  • Housing 
  • Human Rights 
  • Local, State and Federal Government 
  • Policy 
  • Research
  • Media 

Advocates for: 

  • Justice 
  • Education 
  • Drug Law Reform
  • Poverty Eradication
  • Gender Equality 
  • Housing  

Where is Health and Human Rights Summit? plus Created with Sketch.

This year, the Health and Human Rights Summit: Advancing the Wellbeing of People Who Use Drugs will be held at the Crowne Plaza in Adelaide.

I have already been invited to attend the Health and Human Rights Summit on the 9th and 10th Dec, do I need to register for the public sessions? plus Created with Sketch.

No. If you are a member of the AIVL network or an AIVL partner who has been invited to the closed community sessions on the 9th and 10th Dec you are already registered for the public sessions on the 11th.

Stay up to date with our newsletter

This field is for validation purposes and should be left unchanged.